Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|August 19, 2000
Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale groupL Chaillous, H Lefèvre, C Thivolet, et al.
Diabetes Research and Clinical Practice|April 11, 2017
The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE studyJ I Blomster, S Zoungas, M Woodward, et al.
Kidney International|April 12, 2000
Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study GroupC Lacquemant, C Gaucher, C Delorme, et al.
Diabetes Care|June 22, 2000
Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North AfricaM Marre, M Lièvre, D Vasmant, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 26, 2009
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)M Marre, J Shaw, M Brändle, et al.
The Journal of Nutrition, Health & Aging|December 2, 2015
Analysing Time to Event Data in Dementia Prevention Trials: The Example of the GuidAge Study of EGb761B Scherrer, S Andrieu, P J Ousset, et al.
Diabetes Research and Clinical Practice|June 15, 2010
The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trialS Zoungas, J Chalmers, A P Kengne, et al.
Diabetes, Obesity & Metabolism|May 17, 2013
The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitusJ I Blomster, C K Chow, S Zoungas, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouseW Huang, Y Gallois, N Bouby, et al.
Pageof 22